Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
Abstract Surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic requires tests to monitor antibody formation and prevalence. We detected SARS‐CoV‐2 antibodies using red cells coated by Kode technology with short peptides derived from the SARS‐CoV‐2 spike protein (S...
Main Authors: | Christof Weinstock, Willy A. Flegel, Kshitij Srivastava, Sabine Kaiser, Hubert Schrezenmeier, Chrysanthi Tsamadou, Carolin Ludwig, Bernd Jahrsdörfer, Nicolai V. Bovin, Stephen M. Henry |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.352 |
Similar Items
-
mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects
by: Dorit Fabricius, et al.
Published: (2021-08-01) -
Differentially induced immunity in buccal and nasal mucosae after vaccination for SARS–CoV–2: Prospects for mass scale immunity-screening in large populations
by: Chrysanthi Tsamadou, et al.
Published: (2022-11-01) -
Regulatory B Cells—Immunopathological and Prognostic Potential in Humans
by: Johanna Veh, et al.
Published: (2024-02-01) -
Cytokine levels associated with favorable clinical outcome in the CAPSID randomized trial of convalescent plasma in patients with severe COVID-19
by: Sixten Körper, et al.
Published: (2022-10-01) -
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
by: Sixten Körper, et al.
Published: (2022-12-01)